https://www.selleckchem.com/pr....oducts/ttnpb-arotino
35). Patient with ATTR-CA and AF are at increased risk for stroke compared to patients with ATTR-CA and without AF. Thrombotic events and major bleeds did not differ between those who received warfarin and NOACs. Patient with ATTR-CA and AF are at increased risk for stroke compared to patients with ATTR-CA and without AF. Thrombotic events and major bleeds did not differ between those who received warfarin and NOACs.In the UK, in the acute in-patient setting, the only information that a patient receives about their medical
Synes godt om
Kommentar
Del
